|会社名||Teladoc Health Inc （TDOC テラドック・ヘルス）|
|業種||ヘルスケア施設_サ―ビス 医療関連（Health Care）|
|概要||事業概要 テラドック･ヘルス(Teladoc Health Inc.)(旧名:Teladoc Inc.)は遠隔医療会社である。同社はモバイル機器、インターネット、ビデオと電話を通じて、いつでもどこでもオンデマンドヘルスケアを提供するテレヘルスプラットフォームを提供する。同社のソリューションは、上部呼吸器感染症、尿路感染症および副鼻腔炎、皮膚病状、不安および禁煙などの急性診断から、各種病状および症例を治療する3000以上の理事会認定医師および行動医療専門家と会員を結びつける。同社のソリューションは、統合テクノロジープラットフォーム、プロバイダーネットワーク、消費者関与戦略、確立流通チャネルで構成される。 テラドックは、米国の遠隔医療プラットフォ―ム企業。インタ―ネット、ビデオ、携帯電話を利用し、オンデマンドの医療を提供する。登録会員は、上気道感染症、尿路感染症や副鼻腔炎など急性疾患の診断や、皮膚の状態、不安感、禁煙などについて、1100以上の認定医や医療専門家に毎日24時間アクセスできる。本社はニューヨーク州。 Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals.|
|代表者氏名||David B. Snow|
|代表者役職名||Independent Chairman of the Board|
|決算概要||決算概要 BRIEF: For the fiscal year ended 31 December 2018 Teladoc Health Inc revenues increased 79% to $417.9M. Net loss before extraordinary items decreased 17% to $97.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Amortization of warrants and loss on ext decrease from $14.1M (expense) to $0K.|
M&T Bank Corp Has $902,000 Stock Position in Teladoc Health, Inc. (NYSE:TDOC) 2021/12/24 09:52:46 Transcript Daily
M&T Bank Corp lifted its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 2.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,116 shares of the health services providers stock after purchasing an additional 178 shares during the quarter. 
Teladoc Health Inc. (TDOC) Worth Considering For The Next Few Weeks 2021/12/23 12:00:00 Stocks Register
Teladoc Health Inc. (NYSE:TDOC) concluded the trading at $94.38 on Wednesday, December 22 with a fall of -2.41% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $96.71 and 5Y monthly beta was reading 0.38 with its price kept floating in the Teladoc Health Inc. (TDOC) Worth Considering For The Next Few Weeks Read More »
Will Teladoc Recover In 2022? 2021/12/22 11:00:00 The Motley Fool
Last year''s superstar has been lagging behind this year.
UpScript CEO, Peter Ax, Taps Teladoc Veteran Chief Medical Officer 2021/12/22 01:03:00 Business Insider Markets
SCOTTSDALE, Ariz., Dec. 21, 2021 /PRNewswire/ -- UpScript Health, a fully integrated proprietary telehealth and online pharmacy platform connecting life science companies with patients, today announced it has named Dr. Richard Boxer
The Recent Sell-Off Shows the Importance of Valuation 2021/12/21 16:23:08 GuruFocus
Falling stocks lack support from fundamental factors Check out Warren Buffett Stock Picks » Download GuruFolio Report of Warren Buffett (Updated on 12/20/2021) Related Stocks: ARKK , TDOC , BRK.A , BRK.B ,
The Next Frontier: Technology in the Healthcare Space (CLOV, USAQ, AMWL, TDOC) 2021/06/22 12:04:16 Wall Street PR
On its face, it is the perfect marriage of growth and value, of cyclical risk and staple economics. The marriage of technology and healthcare is a potent addition for portfolio strategists and individual investors alike. Demand for Healthcare services is a guarantee, as the clear growth trend associated with that idea as we face an  The post The Next Frontier: Technology in the Healthcare Space (CLOV, USAQ, AMWL, TDOC) appeared first on Wall Street PR .
Babylon Health Stock: Value-Based Care Using Telehealth 2021/06/18 23:44:49 Nanalyze
Last year, we judged Teladoc (TDOC) as the best investment into the telehealth theme and that was just a few months before the companys $18.5 billion blockbuster acquisition of Livongo, which developed an AI platform for managing chronic diseases like diabetes. The business model is all about providing services virtually through apps, chats, and 
Telehealth/Telemedicine Market Report By COVID-19 Outbreak Siemens Healthineers (Germany), Cisco Systems, Inc. (US), Teladoc Health Inc. (US) 2021/06/18 18:37:37 Jumbo News
by Component (Software & Services, RPM, Real-Time), Application (Teleradiology, Telestroke, TeleICU), Hardware (Glucose Meters), End-User (Provider, Payer, patient), Delivery (On-Premise, Cloud) Global Forecast to 2025 The global telehealth/telemedicine market is expected to grow at a CAGR of 37.7% during the forecast period, to reach USD 191.7 billion by 2025 from an estimated USD 38.7 billion 
Med-tech M&As rise above 2020; nearly half of deals are digital health 2021/06/17 17:00:00 BioWorld
The largest med-tech M&As so far in 2021 have bumped the years value well above this point last year, although none come close to the October merger of Teladoc Health Inc. and Livongo Health Inc. for $18.5 billion. Still, 2021 appears on track to exceed 2020s $38 billion M&A total, with 227 completed M&As already valued at $25 billion, 66% of 2020s full-year amount.
Cathie Wood Loads Up More On Peloton, Skillz, Teladoc On The Dip 2021/05/06 05:16:06 Benzinga
Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $48.53 million, in Skillz Inc (NYSE: SKLZ ) on Wednesday. SKLZ shares closed 9% lower at $15.48 on Wednesday and were down 1% in after-hours trading in the aftermath of the company reporting a wider quarterly loss alongside a surge in revenue. Ark owned about 12.9 million shares in Skillz divided between the ARK Innovation ETF (NYSE: ARKK ) and Ark Next Generation Internet ETF (NYSE: ARKW ) ahead of Wednesday's trade, worth about $263.98 million. The New York-based hedge fund had last week come out in support of the company amid short-seller allegations related to its revenue recognition practices and the NFL partnership. See Also: Cathie Wood Loaded Up Further On Skillz On Earnings Day The investment firm also bought 325,805 … Full story available on Benzinga.com
Teladoc Stock Plummets Facing Analyst Price Target Cuts After Wider Than Expected Q1 Loss 2021/04/29 16:50:20 Benzinga
Teladoc Health (NYSE: TDOC ) reported a wider than expected Q1 loss of $1.31 per share which missed the analyst consensus estimate of $0.62, versus a loss of $0.40 a year ago. That steeper net loss stemmed in part from a $68 million increase in stock-based compensation expense, as well as amortization of acquired intangibles related to its Livongo and Intouch Health acquisitions that pulled its bottom line down by $37 million compared to the prior-year period. The biggest hit was due to an $87 million non-cash income tax charge that primarily reflected a valuation allowance on the stock compensation benefits linked to its purchase of Livongo. The company reported quarterly sales of $453.68 million, marginally above the analyst consensus of $451.92 million, up 151% Y/Y. The total visits increased 56% Y/Y to 3.2 million. The company’s revenue increased by 18% sequentially, with part of this growth … Full story available on Benzinga.com
Teladoc Price Targets Cut by Analysts After Earnings - TheStreet 2021/04/29 12:44:42 The Street
Several analysts lower their share-price targets on Teladoc, the online healthcare provider.
Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology 2021/04/20 13:29:29 Benzinga
The following article is sponsored by Biotricity Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. The COVID-19 pandemic shifted life as we knew it prompting the adoption of technological medical approaches. Telemedicine, for example, was widely criticized before and now is one of the most useful tools for better patient management and minimizing disruption in healthcare delivery. In today’s world, only companies that can adapt to new medical needs will be able to thrive. In fact, many companies such as Teladoc Health Inc (NYSE: TDOC ), Medtronic (NYSE: MDT ), Johnson & Johnson (NYSE: JNJ ) and Abbott Laboratories (NYSE: ABT ), among others, create offers specifically in the medtech industry. They understand that the future of healthcare will keep relying heavily on these innovations. Biotricity Inc. (OTCQB: BTCY ), a company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle, is also currently disrupting the market with its products.
Teladoc Health Stock Faces 'Durable Growth Opportunity': Here's Why 2021/04/15 16:36:00 Benzinga
Teladoc Health Inc (NYSE: TDOC ) benefited from increased adoption of telehealth during the 2020 pandemic, according to Needham, and should be able to sustain this elevated growth “on the strength of its expansive platform.” The Teladoc Health Analyst: Ryan MacDonald initiated coverage of Teladoc Health with a Buy rating and a price target of $235. The Teladoc Health Thesis: While Teladoc Health’s stock trades at a premium valuation to its digital health peers, this premium … Full story available on Benzinga.com
関連キーワード （ヘルスケア施設_サ―ビス 米国株 TDOC テラドック・ヘルス TDOC ）